{"id":"W4402037961","doi":"10.1038/s41467-024-51781-0","title":"Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate","year":2024,"lang":"en","type":"article","venue":"Nature Communications","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research; Novo Nordisk Fonden; Novo Nordisk; National Cancer Institute; Lundbeckfonden; Government of Canada; European Molecular Biology Organization; Innovationsfonden; Carlsbergfondet; Danmarks Grundforskningsfond","keywords":"Antibody; Cancer research; Oncofetal antigen; Chondroitin sulfate; Epitope; Cancer; In vivo; Phage display; Biology; Embryonic stem cell; Monoclonal antibody; Immunology; Biochemistry; Glycosaminoglycan; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001014778,0.0002626537,0.0001218063,0.0001981952,0.00007512102,0.0002249367,0.0001654709,0.0002945912,0.0005305214],"category_scores_gemma":[0.00006507451,0.00008267396,0.0001379162,0.0001046597,0.0001358172,0.0001291575,0.0001470556,0.000341108,0.0001487475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003040672,"about_ca_system_score_gemma":0.0001529761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007347689,"about_ca_topic_score_gemma":0.001414378,"domain_scores_codex":[0.9999281,0.000009647568,0.000003328887,0.00001264661,0.00002752879,0.00001866497],"domain_scores_gemma":[0.999966,0.000005400842,0.00001070879,0.000004062046,0.000005829576,0.000007900817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00002502253,0.00002594085,0.0001093876,0.00001936834,0.000003783263,0.00002105803,0.000007932069,0.0001210464,0.9963264,0.0001745277,0.0000421958,0.003123314],"study_design_scores_gemma":[0.000009506817,0.0003122654,0.00121462,0.000003418204,0.000009086647,0.0002285404,0.000006901018,0.001059938,0.9936592,0.00003385901,0.00345975,0.00000291755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9719222,0.0029266,0.01977068,0.000168037,0.00003450194,0.0001049681,0.0001237586,0.0001567803,0.004792448],"genre_scores_gemma":[0.9892328,0.001308216,0.006455623,0.0000780949,0.000006511387,0.00002890746,0.0001350609,0.000009954155,0.002744917],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007347689,"threshold_uncertainty_score":0.002206206,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03308137755021447,"score_gpt":0.3793822776400114,"score_spread":0.3463009000897969,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}